The MUHC's Distinguished Public Lecture Series Begins A Second Season

Main Category: Alzheimer's / Dementia
Also Included In: Diabetes;  Public Health;  Conferences
Article Date: 01 Oct 2007 - 12:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


"From Microscope to Stethoscope," the distinguished public lecture series organized by the Research Institute of the McGill University Health Centre (MUHC), is embarking on a second season. "Again this year, three of our most brilliant researchers invite you on a journey into a possible future, when current research has already turned into innovative treatments for patients," declared Dr. Arthur T. Porter, Director General of the MUHC. These lectures will give you a direct look at the intellectual vitality that fills our research laboratories and the enormous impact of this work on our daily lives.

Dr. Vassilios Papadopoulos, Director of the Research Institute of the MUHC, will open the lecture series on Wednesday, October 3, 2007 by sharing the hope that his current research may bring to patients suffering from Alzheimer's disease. His latest laboratory findings could lead to remarkable therapeutic advances and relieve the difficulties doctors currently have in terms of diagnosis and treatment.

Dr. Lawrence Rosenberg, a world expert in diabetes, will present the second lecture on Monday, November 7, 2007, followed by Dr. Ronald Olivenstein, MUHC Asthma Clinic Director, on Wednesday, December 3, 2007.

The lectures will take place at the Montreal General Hospital in Livingston Hall (Rom L6-500) starting at 7:30 p.m. Admission is free and anyone interested is welcome.

The speakers will take questions from audience members during a discussion period following each lecture.

###

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, a university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 500 researchers, nearly 1000 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. For further details visit: http://www.muhc.ca/research.

The McGill University Health Centre (MUHC) is a comprehensive academic health institution with an international reputation for excellence in clinical programs, research and teaching. The MUHC is a merger of five teaching hospitals affiliated with the Faculty of Medicine at McGill University -- the Montreal Children's, Montreal General, Royal Victoria, and Montreal Neurological Hospitals, as well as the Montreal Chest Institute. Building on the tradition of medical leadership of the founding hospitals, the goal of the MUHC is to provide patient care based on the most advanced knowledge in the health care field, and to contribute to the development of new knowledge. http://www.muhc.ca/

Source: Isabelle Kling
McGill University Health Centre

Article adapted by Medical News Today from original press release.
Visit our alzheimer's / dementia section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Isabelle Kling. "The MUHC's Distinguished Public Lecture Series Begins A Second Season." Medical News Today. MediLexicon, Intl., 1 Oct. 2007. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/84021.php>

APA
Isabelle Kling. (2007, October 1). "The MUHC's Distinguished Public Lecture Series Begins A Second Season." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/84021.php.

Please note: If no author information is provided, the source is cited instead.


Alzheimer's / Dementia

What Is Alzheimer's Disease?

Alzheimer's disease is a progressive neurologic disease of the brain leading to the irreversible loss of neurons and the loss of intellectual abilities, including memory and reasoning. Read more...

What is Dementia?

The word dementia comes from the Latin de meaning "apart" and mens from the genitive mentis meaning "mind". Dementia is the progressive deterioration in cognitive function - the ability to process thought (intelligence). Read more...

Most Popular Articles



Follow Our Alzheimer's News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Alzheimer's / Dementia Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »